Video to Promote HPV Vaccination

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

110 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-07-31

Study Completion Date

2018-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research study is to determine if video-based education will increase HPV vaccination rates among 11 - 17 year olds.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

An Evaluation of Tailored Messages to Address Parental Questions About HPV Vaccination

NCT03628885

Human Papilloma Virus Vaccines Attitude to Health

COMPLETED NA

The STOP-HPV Trial 5: Single Arm Evaluation of the Bundle

NCT03609320

Immunization Vaccination

UNKNOWN NA

The STOP-HPV Trial 1: Communication Intervention

NCT03599557

Immunization Vaccination

COMPLETED NA

The STOP-HPV Trial 4: Bundle Intervention

NCT03609242

Immunization Vaccination

UNKNOWN NA

Communication Strategies to Increase HPV Vaccination Intention

NCT06784960

Papilloma Viral Infection Vaccine Hesitancy Communication

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Human Papillomavirus (HPV) is a common sexually transmitted infection that has the potential to cause cancer. The vaccine is recommended because it prevents the HPV infections that most commonly cause cancer. HPV vaccines offer the best protection to girls and boys who receive the complete, three-vaccine series and have time to develop an immune response before being exposed to HPV. However, vaccination rates are low compared to other vaccines for teens.

Results from this study will help us learn why participants do or do not get the HPV vaccination and whether video-based education can help improve vaccination rates

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vaccine Acceptance Social Acceptance Acceptance Processes Health Behavior Human Papillomavirus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Vaccine Information Statement

Study participants will receive the HPV Vaccine Information Statement (VIS) which is part of routine care.

Group Type NO_INTERVENTION

No interventions assigned to this group

Video & Vaccine Information Statement

Participants will view an educational video about the HPV vaccine with a male or female narrator. Participants will also receive the HPV Vaccine Information Statement (VIS) which is part of routine care.

Group Type EXPERIMENTAL

Educational Video with Male or Female Narrator

Intervention Type OTHER

Participants will watch an educational video about the quadrivalent HPV vaccine (Gardasil) narrated by either a male or female.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Educational Video with Male or Female Narrator

Participants will watch an educational video about the quadrivalent HPV vaccine (Gardasil) narrated by either a male or female.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Parent-child dyads in which the child is a male or female age 11 to 17 years who has not received the HPV vaccine

Exclusion Criteria

* Parent-child dyads in which the child has received the HPV vaccine
* Parent-child dyads in which the child is older than 18 at the time of enrollment
* Non-English speakers

Minimum Eligible Age

11 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes